Do analysts rate OGI or ACB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Does the media refer more to OGI or ACB?

In the previous week, Aurora Cannabis had 10 more articles in the media than Organigram Global. MarketBeat recorded 11 mentions for Aurora Cannabis and 1 mentions for Organigram Global. Aurora Cannabis' average media sentiment score of 0.25 beat Organigram Global's score of 0.16 indicating that Aurora Cannabis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Organigram Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aurora Cannabis 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer OGI or CGC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Canopy Growth 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Does the media favor OGI or CGC?

In the previous week, Canopy Growth had 4 more articles in the media than Organigram Global. MarketBeat recorded 5 mentions for Canopy Growth and 1 mentions for Organigram Global. Canopy Growth's average media sentiment score of 0.82 beat Organigram Global's score of 0.16 indicating that Canopy Growth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Organigram Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Canopy Growth 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend CRON or OGI?

Cronos Group currently has a consensus price target of $2.30, suggesting a potential downside of 30.51%. Given Cronos Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cronos Group is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Does the media refer more to CRON or OGI?

In the previous week, Cronos Group had 3 more articles in the media than Organigram Global. MarketBeat recorded 4 mentions for Cronos Group and 1 mentions for Organigram Global. Cronos Group's average media sentiment score of 0.34 beat Organigram Global's score of 0.16 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Organigram Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer SNDL or OGI?

SNDL currently has a consensus target price of $5.00, suggesting a potential upside of 264.96%. Given SNDL's higher probable upside, equities analysts clearly believe SNDL is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SNDL 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has better earnings and valuation, SNDL or OGI?

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SNDL $677.32M 0.52 -$11.29M -$0.06 N/A Organigram Global $185.07M 0.95 -$17.70M $0.46 2.72

Is SNDL or OGI more profitable?

Organigram Global has a net margin of 28.14% compared to SNDL's net margin of -2.36%. SNDL's return on equity of -2.01% beat Organigram Global's return on equity. Company Net Margins Return on Equity Return on Assets SNDL -2.36% -2.01% -1.67% Organigram Global 28.14% -13.39% -8.67%

Do analysts recommend TLRY or OGI?

Tilray Brands currently has a consensus price target of $11.00, indicating a potential upside of 127.27%. Given Tilray Brands' stronger consensus rating and higher possible upside, research analysts plainly believe Tilray Brands is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 1 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.50 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Does the media prefer TLRY or OGI?

In the previous week, Tilray Brands had 19 more articles in the media than Organigram Global. MarketBeat recorded 20 mentions for Tilray Brands and 1 mentions for Organigram Global. Tilray Brands' average media sentiment score of 0.63 beat Organigram Global's score of 0.16 indicating that Tilray Brands is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tilray Brands 8 Very Positive mention(s) 6 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Organigram Global 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Organigram Global (OGI) Competitors

$1.25 +0.05 (+4.17%)

As of 08/21/2026 04:00 PM Eastern

Compare

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

Should you buy Organigram Global stock or one of its competitors? Organigram Global's main competitors and comparable companies include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), SNDL (SNDL), and Tilray Brands (TLRY). Companies are selected based on similarities in market, industry, and size.

How does Organigram Global compare to Aurora Cannabis?

Organigram Global (NASDAQ:OGI) and Aurora Cannabis (NASDAQ:ACB) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

34.6% of Organigram Global shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Aurora Cannabis had 10 more articles in the media than Organigram Global. MarketBeat recorded 11 mentions for Aurora Cannabis and 1 mentions for Organigram Global. Aurora Cannabis' average media sentiment score of 0.25 beat Organigram Global's score of 0.16 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Organigram Global	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aurora Cannabis	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Organigram Global has a net margin of 28.14% compared to Aurora Cannabis' net margin of -32.26%. Aurora Cannabis' return on equity of 4.37% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	28.14%	-13.39%	-8.67%
Aurora Cannabis	-32.26%	4.37%	3.45%

Organigram Global has higher earnings, but lower revenue than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.95	-$17.70M	$0.46	2.72
Aurora Cannabis	$247.82M	1.03	-$88.13M	-$1.41	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Organigram Global has a beta of 1.46, indicating that its share price is 46% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

Summary

Aurora Cannabis beats Organigram Global on 9 of the 16 factors compared between the two stocks.

How does Organigram Global compare to Canopy Growth?

Organigram Global (NASDAQ:OGI) and Canopy Growth (NASDAQ:CGC) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, media sentiment, profitability, valuation and dividends.

Organigram Global has a net margin of 28.14% compared to Canopy Growth's net margin of -65.33%. Organigram Global's return on equity of -13.39% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	28.14%	-13.39%	-8.67%
Canopy Growth	-65.33%	-21.91%	-14.34%

Organigram Global has higher earnings, but lower revenue than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.95	-$17.70M	$0.46	2.72
Canopy Growth	$251.01M	1.88	-$190.29M	-$0.45	N/A

In the previous week, Canopy Growth had 4 more articles in the media than Organigram Global. MarketBeat recorded 5 mentions for Canopy Growth and 1 mentions for Organigram Global. Canopy Growth's average media sentiment score of 0.82 beat Organigram Global's score of 0.16 indicating that Canopy Growth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Organigram Global	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Canopy Growth	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Organigram Global has a beta of 1.46, suggesting that its share price is 46% more volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market.

34.6% of Organigram Global shares are owned by institutional investors. Comparatively, 3.3% of Canopy Growth shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by company insiders. Comparatively, 0.4% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Canopy Growth	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Organigram Global beats Canopy Growth on 9 of the 14 factors compared between the two stocks.

How does Organigram Global compare to Cronos Group?

Cronos Group (NASDAQ:CRON) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment, risk and earnings.

Cronos Group currently has a consensus price target of $2.30, suggesting a potential downside of 30.51%. Given Cronos Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cronos Group is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Cronos Group had 3 more articles in the media than Organigram Global. MarketBeat recorded 4 mentions for Cronos Group and 1 mentions for Organigram Global. Cronos Group's average media sentiment score of 0.34 beat Organigram Global's score of 0.16 indicating that Cronos Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cronos Group	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Organigram Global	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

8.7% of Cronos Group shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 7.8% of Cronos Group shares are held by company insiders. Comparatively, 0.1% of Organigram Global shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cronos Group has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.46, suggesting that its share price is 46% more volatile than the broader market.

Cronos Group has higher earnings, but lower revenue than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	8.37	-$9.45M	$0.20	16.55
Organigram Global	$185.07M	0.95	-$17.70M	$0.46	2.72

Cronos Group has a net margin of 39.08% compared to Organigram Global's net margin of 28.14%. Cronos Group's return on equity of 4.85% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	39.08%	4.85%	4.62%
Organigram Global	28.14%	-13.39%	-8.67%

Summary

Cronos Group beats Organigram Global on 11 of the 15 factors compared between the two stocks.

How does Organigram Global compare to SNDL?

SNDL (NASDAQ:SNDL) and Organigram Global (NASDAQ:OGI) are related small-cap companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

In the previous week, Organigram Global had 1 more articles in the media than SNDL. MarketBeat recorded 1 mentions for Organigram Global and 0 mentions for SNDL. SNDL's average media sentiment score of 0.45 beat Organigram Global's score of 0.16 indicating that SNDL is being referred to more favorably in the media.

Company	Overall Sentiment
SNDL	Neutral
Organigram Global	Neutral

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$677.32M	0.52	-$11.29M	-$0.06	N/A
Organigram Global	$185.07M	0.95	-$17.70M	$0.46	2.72

SNDL currently has a consensus target price of $5.00, suggesting a potential upside of 264.96%. Given SNDL's higher probable upside, equities analysts clearly believe SNDL is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

SNDL has a beta of 0.93, meaning that its stock price is 7% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.46, meaning that its stock price is 46% more volatile than the broader market.

Organigram Global has a net margin of 28.14% compared to SNDL's net margin of -2.36%. SNDL's return on equity of -2.01% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-2.36%	-2.01%	-1.67%
Organigram Global	28.14%	-13.39%	-8.67%

34.6% of Organigram Global shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Organigram Global beats SNDL on 10 of the 16 factors compared between the two stocks.

How does Organigram Global compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Organigram Global (NASDAQ:OGI) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment and valuation.

Organigram Global has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$915.45M	0.72	-$121.40M	-$1.08	N/A
Organigram Global	$185.07M	0.95	-$17.70M	$0.46	2.72

Tilray Brands has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market. Comparatively, Organigram Global has a beta of 1.46, suggesting that its stock price is 46% more volatile than the broader market.

Organigram Global has a net margin of 28.14% compared to Tilray Brands' net margin of -13.11%. Tilray Brands' return on equity of -7.76% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-13.11%	-7.76%	-5.59%
Organigram Global	28.14%	-13.39%	-8.67%

Tilray Brands currently has a consensus price target of $11.00, indicating a potential upside of 127.27%. Given Tilray Brands' stronger consensus rating and higher possible upside, research analysts plainly believe Tilray Brands is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.50
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Tilray Brands had 19 more articles in the media than Organigram Global. MarketBeat recorded 20 mentions for Tilray Brands and 1 mentions for Organigram Global. Tilray Brands' average media sentiment score of 0.63 beat Organigram Global's score of 0.16 indicating that Tilray Brands is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tilray Brands	8 Very Positive mention(s)	6 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Organigram Global	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

9.4% of Tilray Brands shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.8% of Tilray Brands shares are held by company insiders. Comparatively, 0.1% of Organigram Global shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Tilray Brands beats Organigram Global on 11 of the 17 factors compared between the two stocks.

Get Organigram Global News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OGI vs. The Competition

Export

Metric	Organigram Global	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$176.22M	$6.02B	$7.37B	$12.85B
Dividend Yield	N/A	1.74%	2.53%	11.08%
P/E Ratio	2.72	26.67	272.60	24.25
Price / Sales	0.95	71.61	624.33	101.47
Price / Cash	N/A	33.24	78.62	53.99
Price / Book	0.50	6.23	13.05	6.20
Net Income	-$17.70M	$150.07M	$3.47B	$348.59M
7 Day Performance	1.63%	0.69%	2.09%	0.08%
1 Month Performance	35.93%	8.91%	6.64%	3.88%
1 Year Performance	-21.88%	8.07%	25.02%	16.98%

Organigram Global Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
OGI Organigram Global	1.4826 of 5 stars	$1.25 +4.2%	N/A	-21.9%	$176.22M	$185.07M	2.72	1,139
ACB Aurora Cannabis	1.4449 of 5 stars	$3.67 +1.9%	N/A	-21.0%	$237.97M	$314.07M	N/A	1,028
CGC Canopy Growth	0.8863 of 5 stars	$0.99 -1.0%	N/A	-17.3%	$443.80M	$293.63M	N/A	1,128
CRON Cronos Group	1.5283 of 5 stars	$3.21 +1.9%	$2.30 -28.3%	+27.3%	$1.19B	$179.09M	16.05	450
SNDL SNDL	2.9206 of 5 stars	$1.23 flat	$5.00 +306.5%	-39.1%	$316.60M	$928.39M	N/A	2,751

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OGI) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Organigram Global (OGI) Competitors

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

How does Organigram Global compare to Aurora Cannabis?

Summary

How does Organigram Global compare to Canopy Growth?

Summary

How does Organigram Global compare to Cronos Group?

Summary

How does Organigram Global compare to SNDL?

Summary

How does Organigram Global compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OGI vs. The Competition

Organigram Global Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Organigram Global (OGI) Competitors

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

How does Organigram Global compare to Aurora Cannabis?

Do insiders and institutionals hold more shares of OGI or ACB?

Does the media refer more to OGI or ACB?

Is OGI or ACB more profitable?

Which has better earnings & valuation, OGI or ACB?

Do analysts rate OGI or ACB?

Which has more risk & volatility, OGI or ACB?

Summary

How does Organigram Global compare to Canopy Growth?

Is OGI or CGC more profitable?

Which has preferable earnings & valuation, OGI or CGC?

Does the media favor OGI or CGC?

Which has more volatility & risk, OGI or CGC?

Do insiders and institutionals hold more shares of OGI or CGC?

Do analysts prefer OGI or CGC?

Summary

How does Organigram Global compare to Cronos Group?

Do analysts recommend CRON or OGI?

Does the media refer more to CRON or OGI?

Do institutionals & insiders hold more shares of CRON or OGI?

Which has more risk & volatility, CRON or OGI?

Which has better valuation and earnings, CRON or OGI?

Is CRON or OGI more profitable?

Summary

How does Organigram Global compare to SNDL?

Does the media refer more to SNDL or OGI?

Which has better earnings and valuation, SNDL or OGI?

Do analysts prefer SNDL or OGI?

Which has more volatility and risk, SNDL or OGI?

Is SNDL or OGI more profitable?

Do institutionals and insiders hold more shares of SNDL or OGI?

Summary

How does Organigram Global compare to Tilray Brands?

Which has preferable valuation & earnings, TLRY or OGI?

Which has more risk and volatility, TLRY or OGI?

Is TLRY or OGI more profitable?

Do analysts recommend TLRY or OGI?

Does the media prefer TLRY or OGI?

Do insiders and institutionals hold more shares of TLRY or OGI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OGI vs. The Competition

Organigram Global Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools